EUROFINS SCIENT (OTCMKTS:ERFSF) Shares Down 3.2% - Here's Why

Key Points

• The shares of EUROFINS SCIENT fell by 3.2% on Wednesday, trading at $73.40, with a notable decrease in trading volume.
• Analysts have mainly given the stock a neutral rating, with one strong buy and five hold ratings reflecting a current average rating of "Hold."
• EUROFINS SCIENT has a solid financial structure with a current ratio of 1.26 and a debt-to-equity ratio of 0.77, indicating good liquidity and manageable debt levels.

EUROFINS SCIENT (OTCMKTS:ERFSF - Get Free Report)'s share price fell 3.2% on Wednesday . The stock traded as low as $73.40 and last traded at $73.40. 245 shares traded hands during mid-day trading, a decline of 84% from the average session volume of 1,500 shares. The stock had previously closed at $75.84.

Wall Street Analyst Weigh In

Separately, Citigroup restated a "neutral" rating on shares of EUROFINS SCIENT in a research report on Friday, July 25th. One analyst has rated the stock with a Strong Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold".

EUROFINS SCIENT Stock Performance

The stock has a 50-day moving average price of $76.01 and a 200 day moving average price of $66.66. The company has a current ratio of 1.26, a quick ratio of 1.19 and a debt-to-equity ratio of 0.77.

About EUROFINS SCIENT

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.